PAZOO, INC. Inactive Instrument
Pazoo, Inc. Stock Other OTC
Equities
PZOO
US70454Q3048
Healthcare Facilities & Services
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2016 | 30.52K 41.91K | Sales 2017 | - | Capitalization | 395K 543K |
|---|---|---|---|---|---|
| Net income 2016 | -8M -10.99M | Net income 2017 | -3M -4.12M | EV / Sales 2016 | 127 x |
| Net Debt 2016 | 3.44M 4.73M | Net Debt 2017 | 3.05M 4.18M | EV / Sales 2017 | - |
| P/E ratio 2016 |
-0.01
x | P/E ratio 2017 |
-0.03
x | Employees | - |
| Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 99.91% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Basloe
CEO | Chief Executive Officer | 73 | - |
Ben Hoehn
DFI | Director of Finance/CFO | 43 | 11-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Steven Basloe
CEO | Chief Executive Officer | 73 | - |
Ben Hoehn
DFI | Director of Finance/CFO | 43 | 11-08-31 |
Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.21% | 8.46B | |
| +45.61% | 3.88B | |
| -36.69% | 2.63B | |
| -8.06% | 2.45B | |
| -9.64% | 2.31B | |
| -6.49% | 1.99B | |
| -17.24% | 1.61B | |
| -37.21% | 1.3B | |
| +5.14% | 1.09B |
